InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
无可用的信号评分。
Explore the full record of transactions filed by Smith Christopher Charles. Director active across 1 company, notably Park Dental Partners, Inc.. Cumulatively, 1 disclosures have been published. Split: 1 buy · 0 sell. Total volume traded: €86k. Activity tracked since 3 December 2025. The latest transaction was disclosed on 3 December 2025 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条